<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2019 [PPXK5GW761L0VHT4GKPY]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:10pt Times New Roman;margin:0'><B>UNITED STATES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Washington, D. C. 20549</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Pursuant to Section 13 Or 15(d) of the</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Securities Exchange Act of 1934</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Date of Report (Date of earliest event reported): July 26, 2019 </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>GB Sciences, Inc.</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Exact name of Registrant as specified in its charter)</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>Nevada</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(State or other Jurisdiction of <BR>Incorporation or organization)</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>000-55462</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Commission File Number)</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>59-3733133</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(IRS Employer I.D. No.)</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>3550 W. Teco Avenue</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Las Vegas, Nevada 89118  </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Phone: (844) 843-2569</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Address, including zip code, and telephone number, including area code, of</P>
<P align=center style='font:10pt Times New Roman;margin:0'>registrant&#8217;s principal executive offices)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>N/A</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Former name, former address and former fiscal year, if changed since last report)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt>  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:0pt'><FONT style=font-size:10pt> </FONT></KBD><KBD style='position:absolute;font:10pt Times New Roman;margin-left:36pt'><FONT style=font-size:10pt> </FONT></KBD><KBD style=margin-left:72pt></KBD><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt>  Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:0pt'><FONT style=font-size:10pt> </FONT></KBD><KBD style='position:absolute;font:10pt Times New Roman;margin-left:36pt'><FONT style=font-size:10pt> </FONT></KBD><KBD style=margin-left:72pt></KBD><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt>  Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:0pt'><FONT style=font-size:10pt> </FONT></KBD><KBD style='position:absolute;font:10pt Times New Roman;margin-left:36pt'><FONT style=font-size:10pt> </FONT></KBD><KBD style=margin-left:72pt></KBD><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font:10pt Segoe UI Symbol'>&#9744;</FONT><FONT style=font-size:10pt>  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><FONT style=font-size:10pt><B>ITEM 8.01  Other Events</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><FONT style=font-size:10pt>GB Sciences, Inc. (the &#8220;Company&#8221; or &#8220;Registrant&#8221;) received an unsolicited $15,000,000 offer for its 50% interest in GB Sciences Louisiana LLC. The Company declined the offer. &nbsp;The Company will inform shareholders if there are any material developments in the dialogue with the proposed purchaser.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>SIGNATURE PAGE</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:98%><TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=top><P style='font:10pt Times New Roman;margin:0'><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;&nbsp;GB Sciences, Inc.</B></P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>Dated: July 26, 2019</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>By: </P>
</TD><TD valign=top style='border-bottom:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'>/s/ John Poss</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'>John Poss</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'>Chief Executive Officer </P>
</TD><TD valign=middle><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:15pt 0 0 0'><P align=center style='font:10pt Calibri;margin:0'>1</P>
<P style='font:10pt Calibri;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "gblx_8k.htm", "description": "8-K", "secsgml_size_bytes": 9579}]
{"company-data": {"conformed-name": "GB SCIENCES INC", "cik": "0001165320", "assigned-sic": "1311", "irs-number": "593733133", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-55462", "film-number": "19978334"}, "business-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118", "phone": "(844) 843-2569"}, "mail-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118"}, "former-company": [{"former-conformed-name": "Growblox Sciences, Inc.", "date-changed": "20140603"}, {"former-conformed-name": "Signature Exploration & Production Corp.", "date-changed": "20080602"}, {"former-conformed-name": "Diabetic Treatment Centers of America, Inc.", "date-changed": "20040812"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 26, 2019
GB Sciences, Inc.
(Exact name of Registrant as specified in its charter)
Nevada
(State or other Jurisdiction of
Incorporation or organization)
000-55462
(Commission File Number)
59-3733133
(IRS Employer I.D. No.)
3550 W. Teco Avenue
Las Vegas, Nevada 89118
Phone: (844) 843-2569
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)
☐
Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))
ITEM 8.01  Other Events
GB Sciences, Inc. (the "Company" or "Registrant") received an unsolicited $15,000,000 offer for its 50% interest in GB Sciences Louisiana LLC. The Company declined the offer.  The Company will inform shareholders if there are any material developments in the dialogue with the proposed purchaser.
SIGNATURE PAGE
Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GB Sciences, Inc.
Dated: July 26, 2019
By:
/s/ John Poss
John Poss
Chief Executive Officer
1